All News
Filter News
Found 808,967 articles
-
He Jiankui, a researcher in Shenzhen, China, claims he utilized CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples. The gene editing was done to give the children protection from HIV, which each of the fathers carried.
-
One company, Life Biosciences, is taking a broad—yet also specific—approach to longevity and diseases of aging. Co-founder and chairman David Sinclair took time to talk to BioSpace about the company.
-
Shares of Boston-based Zafgen, Inc. plunged more than 32 percent in pre-market trading after the company announced the U.S. Food and Drug Administration has slapped a clinical hold on its plans to launch a clinical trial in the United States for an experimental diabetes medicine due to safety con...
-
AbbVie could be eyeing another potential billion dollars of annual revenue following the accelerated approval of Venclexta for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are age 75 years or older or who cannot tolerate intensive chemotherapy.
-
The U.S. Food and Drug Administration will update its review process for the approval of medical devices in the wake of a report that showed more than 80,000 injuries have been associated with medical devices for pain management since 2008.
-
Vectura was studying VR475, a drug-device combination consisting of budesonide delivered by Vectura's proprietary nebulizer inhalation system as a treatment for adolescent and adult patients with severe uncontrolled asthma.
-
Bristol-Myers Squibb and LabCentral, a Cambridge, Mass.-based shared laboratory space, announced the two winners of the Bristol-Myers Squibb’s 2018 Golden Tickets for LabCentral. Due to being a platinum sponsor, Bristol-Myers Squibb could choose up to two innovative life science companies per yea...
-
BioSpace Movers and Shakers: Nov. 26
11/26/2018
In a short week leading up to Thanksgiving, several companies made leadership changes as they eye the coming year. We round up who made power moves this past week. -
BrainGate's Technology Allows Quadriplegic Individuals to Control a Tablet With Their Thoughts
11/26/2018
Three patients with quadriplegia were implanted with the BrainGate BCI, a sensor about the size of a baby aspirin. It can detect signals in the motor cortex. These were decoded and routed to a Bluetooth device that acts as a wireless mouse. -
Of course, everyone wants to start a new job off on the right foot, so to speak, but sometimes the little things that can make a big difference that first week can get lost amid a flurry of meetings, understanding, new tasks and projects, onboarding, catching up, and in general just getting yours...
-
Largest Medical AI Imaging Technology Platform Adds Capabilities to Speed Radiology Reports for More Conditions
11/26/2018
Infervision, a tech company using big data and artificial intelligence (AI) to assist and improve medical diagnoses, announced the launch of InferRead CT Chest, a new product concept that detects four different conditions with just one set of chest scans, leading to faster and more comprehensive medical diagnoses.
-
NanoViricides Files Quarterly Report for Period Ending September 30, 2018
11/26/2018
NanoViricides, Inc. filed its quarterly report for its first quarter of financial year 2019 in a timely manner with the Securities and Exchange Commission.
-
CytoSorbents to Present at the 30th Annual Piper Jaffray Healthcare Conference
11/26/2018
CytoSorbents Corporation will present an overview of the company at the 30th Annual Piper Jaffray Healthcare Conference in New York City on November 29, 2018.
-
Sutro to Participate in the 30th Annual Piper Jaffray Healthcare Conference
11/26/2018
Sutro Biopharma, Inc. will present at the 30th Annual Piper Jaffray Healthcare Conference.
-
Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to ReviveMed, Strand Therapeutics
11/26/2018
Bristol-Myers Squibb Company and LabCentral today announced that ReviveMed and Strand Therapeutics are the winners of Bristol-Myers Squibb’s 2018 Golden Tickets for LabCentral.
-
Karmanos Cancer Institute recognizes its 2018 Heroes of Cancer
11/26/2018
Inspiring champions who advocate for and support those with cancer
-
NanoSphere Develops New Product Eliminating Need to Smoke Cannabis
11/26/2018
NanoSphere Health Sciences Inc. is pleased to announce the Company has developed a new intraoral delivered cannabis product for the Canadian market, which produces similar effects to smoking cannabis, but is safer and more effective than edibles.
-
Seattle Genetics to Webcast Investor and Analyst Event at the 60th American Society of Hematology Annual Meeting
11/26/2018
Seattle Genetics, Inc. announced today that the company will webcast an investor and analyst event on Monday, December 3, 2018 during the 60th American Society of Hematology (ASH) Annual Meeting in San Diego, Calif.
-
Machavert Pharmaceuticals Unveils a New Bioactive Lipid Drug Candidate for Cancer Treatment
11/26/2018
A poster presentation reporting anti-proliferation activity for MP1000 in human KRAS mutant solid tumor models and hematological tumor models
-
BiondVax CEO to Present at 'World Vaccine Congress 2018 San Diego' About BiondVax's Phase 3 Universal Flu Vaccine Candidate
11/26/2018
BiondVax Pharmaceuticals Ltd. reported today it will present this week at the World Vaccine & Immunotherapy Congress West Coast 2018 in San Diego.